Topic picture, symbol photo: Corona vaccine. Pfizer and BioNTech Announce Successful First Interim Analysis of their COVID-19 Vaccine Candidate in Current Phase 3 Trial A hand wrapped in rubber gloves holds a disposable syringe of vaccine for injection in a needle BIONTECH biotechnology company. | usage worldwide
Tunisia and the two laboratories Pfizer and BioNtech have signed a deal for the purchase of the vaccine against the coronavirus that they have generated.
In a press release by the laboratory, the first batches will be imported by Tunisia in 2021 after receiving all the required agreements.
The representative of Pfizer in Tunisia and Libya Walid Lakhedher described in this sense that the vaccine will be imported into Tunisia as soon as possible, without providing further details.
According to the director of the Pasteur Institute, Hechmi Louzir, Tunisia should receive the first batch of the vaccine against the Coronavirus at the end of March 2021.
In an unprecedented decision, Turkey stopped, as of Thursday, all its commercial transactions with Israel,…
Poilictian Mohamed Abbou stated Thursday that “he will not partake in the next presidential elections because…
President of the Republic, Kais Saied, welcomed, today, Thursday, May 2, 2024, at Carthage Palace,…
The United Nations Development Programme (UNDP) statedon Thursday that it estimates the reconstruction of the…
It appears from an analysis issued by ITCEQ on “the digitalization of administrative services in…
The commissioner general of the UN Agency for Employment of Palestinian Refugees (UNRWA), Philippe Lazzarini,…
This website uses cookies.